ES
26
14
MOS
38
2
UNH
44
2
STI
21
9
MO
44
-3
MTCH
71
9
BLK
50
3
HIG
50
2
RRC
58
6
ADT
25
11
CINF
35
11
NWS
75
4
CCL
64
-6
GOOGL
64
2
WY
36
5
NOV
47
2
LUV
48
3
HAL
30
-10
XRX
59
11
CNP
52
-7
ES
26
14
MOS
38
2
UNH
44
2
STI
21
9
MO
44
-3
MTCH
71
9
BLK
50
3
HIG
50
2
RRC
58
6
ADT
25
11
CINF
35
11
NWS
75
4
CCL
64
-6
GOOGL
64
2
WY
36
5
NOV
47
2
LUV
48
3
HAL
30
-10
XRX
59
11
CNP
52
-7
Financhill
Back

Expedia Group 10K Form

Buy
86

EXPE
Expedia Group

Last Price:
$189.86
Seasonality Move:
1.93%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EXPE News And Ratings

See the #1 stock for the next 7 days that we like better than EXPE

EXPE Financial Statistics

Sales & Book Value

Annual Sales: $12.8B
Cash Flow: $-1.7B
Price / Cash Flow: 13.7
Annual Sales: $10.26
Price / Book: 18.33

Profitability

EPS (TTM): 7.77000
Net Income (TTM): $1.1B
Gross Margin: $11.3B
Return on Equity: 42.54%
Return on Assets: 4.51%

Expedia Group Earnings Forecast

Key Expedia Group Financial Ratios

  • The Gross Profit Margin over the past 21 years for EXPE is 87.75%.
  • The Selling, General & Administrative Expenses for EXPE have been equal to 59.46% of Gross Profit Margin.
  • The Research & Development expenses have been 10.58% of Revenue.
  • The Interest Expense is 30.74% of Operating Income.
  • The Net Earning history of EXPE is 6.21% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 17 years.

Expedia Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Hotels, Restaurants & Leisure
Sector: Consumer Discretionary
Current Symbol: EXPE
CUSIP: 30212P
Website: expediagroup.com

Debt

Debt-to-Equity Ratio: 4.74
Current Ratio: 0.73
Quick Ratio: 0.59

Price-to-Earnings

Trailing P/E Ratio: 35.56
Forward P/E Ratio: 13.34

EXPE Technical Analysis vs Fundamental Analysis

Buy
86
Expedia Group (EXPE) is a Buy

Is Expedia Group a Buy or a Sell?

  • Expedia Group stock is rated a Buy
    The current Expedia Group [EXPE] share price is $188.84. The Score for EXPE is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.